Watershed Asset Management, L.L.C. Bristol Myers Squibb CO Transaction History

Watershed Asset Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $37 - $22,053	287 Added 9.03%	3,465 $246,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $55,118 - $60,704	-759 Reduced 19.28%	3,178 $245,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $242,046 - $290,235	3,937 New	3,937 $288,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Watershed Asset Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Watershed Asset Management, L.L.C. with notifications on news.